Cargando…
PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption
Osteogenesis is an orchestrated process regulated by osteoclastogenesis and osteoblastogenesis. Excessive osteoclastogenesis causes bone diseases, such as osteoporosis. Although a few drugs are effective in osteoporosis treatment, these drugs lead to side effects, including cellulitis, flatulence, a...
Autores principales: | Cho, Eunjin, Chen, Zhihao, Lee, Jinkyung, Lee, Sunwoo, Lee, Tae-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767254/ https://www.ncbi.nlm.nih.gov/pubmed/31540026 http://dx.doi.org/10.3390/molecules24183346 |
Ejemplares similares
-
Inhibitory Effects of N-[2-(4-acetyl-1-piperazinyl) phenyl]-2-(2-chlorophenoxy) acetamide on Osteoclast Differentiation In Vitro via the Downregulation of TRAF6
por: Chen, Zhihao, et al.
Publicado: (2019) -
Inhibition of Osteoclast Differentiation and Bone Resorption by Bisphosphonate-conjugated Gold Nanoparticles
por: Lee, Donghyun, et al.
Publicado: (2016) -
Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption
por: Jang, Jin Sun, et al.
Publicado: (2019) -
N‐[2‐(4‐benzoyl‐1‐piperazinyl)phenyl]‐2‐(4‐chlorophenoxy) acetamide is a novel inhibitor of resorptive bone loss in mice
por: Chen, Zhihao, et al.
Publicado: (2020) -
Crucial Role of Lysine-Specific Histone Demethylase 1 in RANKL-Mediated Osteoclast Differentiation
por: Ding, Mina, et al.
Publicado: (2023)